- Country: Russia
- Summary: Purchase of the Drug Zuclopenthixol for the Treatment of Patients with Schizophrenia and Epilepsy (L252900) in 2025
- RUT Ref No: 112487992
- Deadline: 10 Jan 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: 720630.00
- Notice Type: Tender
- Document Ref. No.: 0348200081024005733
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Purchase of the drug Zuclopenthixol for the treatment of patients with schizophrenia and epilepsy (L252900) in 2025
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPurchase of the Drug Zuclopenthixol for the Treatment of Patients with Schizophrenia and Epilepsy (L252900) in 2025 - Russia Tender
The STATE PUBLIC INSTITUTION OF THE MOSCOW REGION "DIRECTORATE OF THE SINGLE CUSTOMER OF THE MINISTRY OF HEALTH OF THE MOSCOW REGION, a Government sector organization in Russia, has announced a new tender for Purchase of the Drug Zuclopenthixol for the Treatment of Patients with Schizophrenia and Epilepsy (L252900) in 2025. This tender is published on RussiaTenders under RUT Ref No: 112487992 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-01-10.
The estimated tender value is 720630.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
